Jaisim Shah, Director at Sorrento Therapeutics, Inc. (SRNE), bought 10,000 shares at $5.15 ($52K) on 2017-02-03, disclosed to the SEC on 2017-02-03.
Open-market purchase of $52k SRNE by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| SCLX | BUY | 2024-10-17 | $30K | — | Filing → |
| SCLX | BUY | 2024-05-17 | $244K | — | Filing → |
| SRNE | BUY | 2017-06-15 | $18K | — | Filing → |